Home > Healthcare > Analytical Instruments > Molecular Analysis > Tangential Flow Filtration Market

Tangential Flow Filtration Market Trends

Report ID: GMI6505
Published Date: Aug 2023
Report Format: PDF

Download Free Sample

Tangential Flow Filtration Market Trends

The increasing adoption of single-use bioprocessing systems in biopharmaceutical manufacturing is expected to spur the industry expansion. These systems offer several advantages that streamline bioprocessing workflows and enhance product quality. Also, by eliminating the need for complex cleaning and validation procedures between processes, single-use TFF systems reduce downtime and improve operational efficiency. Moreover, their ability to minimize the risk of cross-contamination ensures product purity and safety, meeting the stringent regulatory standards. Further, single-use TFF systems provide scalability and cost-effectiveness, making them an attractive option for both small-scale research and large-scale commercial production.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market size for tangential flow filtration was USD 1.8 billion in 2022 and will reach USD 5.5 billion by 2032 due to the growing prevalence of chronic diseases along with increasing focus on precision medicine & personalized therapies worldwide.

The microfiltration technology segment in the tangential flow filtration industry registered 45.7% share in 2022 and is expected to witness significant growth by 2032 impelled by the high demand for minimized clogging and smoother filtration processes.

North America recorded 44.3% share of the industry in 2022 and will witness substantial CAGR through 2032 due to the growing presence of numerous prominent pharmaceutical and biotechnology companies in the region.

Some of the influential tangential flow filtration companies are REPLIGEN CORPORATION, ABEC, INC., Merck KGaA, Sterlitech Corporation, and Synder Filtration, Inc.